AMRI Share Price

Open 16.39 Change Price %
High 16.57 1 Day -0.16 -0.98
Low 16.15 1 Week -1.11 -6.40
Close 16.23 1 Month 1.66 11.39
Volume 189158 1 Year -3.55 -17.95
52 Week High 20.59
52 Week Low 0.00
AMRI Important Levels
Resistance 2 16.62
Resistance 1 16.46
Pivot 16.32
Support 1 16.00
Support 2 15.84
NASDAQ USA Most Active Stocks
SIRI 4.30 -5.49%
FNFG 10.18 -0.20%
DELL 13.86 0.22%
RFMD 16.59 -2.07%
RIMM 13.03 0.39%
BBEP 0.12 0.00%
GTAT 0.44 0.00%
SUSQ 14.20 -0.77%
QQQ 115.67 0.17%
WRES 0.09 0.00%
More..
NASDAQ USA Top Gainers Stocks
QKLS 0.21 110.00%
LOCM 0.09 50.00%
BSDM 0.62 26.53%
SNTA 0.34 25.93%
OTT 2.39 25.13%
PERF 1.90 22.58%
ASNA 7.01 20.24%
SBSA 4.60 17.95%
CEMP 7.55 15.27%
XXIA 15.55 14.76%
More..
NASDAQ USA Top Losers Stocks
PTIX 0.00 -100.00%
TXCC 0.01 -95.00%
HCIIP 10.10 -67.52%
CRMB 0.27 -57.81%
KIOR 0.03 -57.14%
AMCF 0.03 -50.00%
OPXAW 0.01 -50.00%
VALV 0.03 -50.00%
OSH 0.26 -49.02%
OSH 0.26 -49.02%
More..

Albany Molecular Research, Inc. (NASDAQ: AMRI)

AMRI Technical Analysis 1.5
As on 2nd Dec 2016 AMRI Share Price closed @ 16.23 and we RECOMMEND Buy for LONG-TERM with Stoploss of 15.32 & Sell for SHORT-TERM with Stoploss of 16.42 we also expect STOCK to react on Following IMPORTANT LEVELS.
AMRI Target for December
1st Target up-side 18.72
2nd Target up-side 20.03
3rd Target up-side 21.34
1st Target down-side 14.98
2nd Target down-side 13.67
3rd Target down-side 12.36
AMRI Other Details
Segment EQ
Market Capital 115522384.00
Sector Healthcare
Industry Biotechnology
Offical website http://www.amriglobal.com
AMRI Address
AMRI
26 Corporate Circle
Albany, NY 12212
United States
Phone: 518-512-2000
Fax: 518-512-2020
Interactive Technical Analysis Chart Albany Molecular Research, Inc. ( AMRI NASDAQ USA )
Java support must be enabled in order to display FnCharts.
You can download Java from http://www.java.com
Your Comments and Response on Albany Molecular Research, Inc.
AMRI Business Profile
Albany Molecular Research, Inc. (AMRI), incorporated on June 20, 1991, is a contract research and manufacturing company. The Company provides customers with fully integrated drug discovery, development and manufacturing services. The Company operates in two segments: Large Scale Manufacturing (LSM) and Discovery, Drug Development and Small Scale Manufacturing (DDS). Its LSM segment activities include pilot to commercial scale production of active pharmaceutical ingredients and intermediates, sterile syringe and vial filling and high potency and controlled substance manufacturing and its remaining activities, including drug lead discovery, optimization, drug development, and small scale commercial manufacturing represent its DDS business segment. AMRI supplies a range of services and technologies that support the discovery and development of pharmaceutical products and the manufacturing of active pharmaceutical ingredients (API) and drug product for existing and experimental new drugs. AMRI performs integrated drug discovery programs. The Company’s drug discovery services include assay development and design, screening, screening libraries, natural product services, medicinal chemistry , computer-aided drug discovery (CADD), in vitro admet , bioanalytical services , network of pharmacology service providers and provision of in sourced services. The Company, in its assay development and design Services offers custom assay design and development services to clients in the pharmaceutical, biopharmaceutical and agrochemical industries who are starting from a target or who are supporting ongoing lead discovery programs. This service can be delivered independently to a client, or integrated with its range of drug discovery services. The Company’s offering of screening capabilities, coupled with access to its range of sample collections, give customers the tools to identify and optimize lead compounds. In Its screening libraries services the Company had created a series of small molecule synthetic compound libraries and a complementary collection of natural product extracts from marine, plant and microbial sources designed for screening and hit-to-lead programs. Its libraries include natural products libraries, target focused discovery libraries, commercial sample library, diverse AMRI sample library and diverse fragment based library.